Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Regul Toxicol Pharmacol ; 117: 104779, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32888975

RESUMEN

Maize plants containing event DP-2Ø2216-6 (DP202216), which confers herbicide tolerance through expression of phosphinothricin acetyltransferase and enhanced grain yield potential via temporal modulation of the native ZMM28 protein, were developed for commercialization. To address current regulatory expectations, a mandatory 90-day rodent feeding study was conducted to support the safety assessment. Diets containing 50% by weight of ground maize grain from DP202216, non-transgenic control, and 3 non-transgenic reference varieties, were fully characterized, along with the grain, and diets were fed to Crl:CD®(SD) rats for at least 90 days. As anticipated, no biologically-relevant effects or toxicologically-significant differences were observed on survival, body weight/gain, food consumption/efficiency, clinical and neurobehavioral evaluations, ophthalmology, clinical pathology (hematology, coagulation, clinical chemistry, urinalysis), organ weights, or gross and microscopic pathology parameters in rats fed a diet containing up to 50% DP202216 maize grain when compared with rats fed diets containing control or reference maize grains. The results of this study support the conclusion that maize grain from plants containing event DP-2Ø2216-6 is as safe and nutritious as maize grain not containing the event and add to the significant existing database of rodent subchronic studies demonstrating the absence of hazards from consumption of edible fractions of genetically modified plants.


Asunto(s)
Aminobutiratos/administración & dosificación , Alimentación Animal , Ingestión de Alimentos/efectos de los fármacos , Herbicidas/administración & dosificación , Plantas Modificadas Genéticamente , Zea mays , Aminobutiratos/toxicidad , Alimentación Animal/toxicidad , Animales , Peso Corporal/efectos de los fármacos , Peso Corporal/fisiología , Ingestión de Alimentos/fisiología , Femenino , Herbicidas/toxicidad , Masculino , Plantas Modificadas Genéticamente/toxicidad , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Zea mays/toxicidad
2.
Food Chem Toxicol ; 66: 173-84, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24491265

RESUMEN

The potential health effects of meal and oil processed from seed of genetically modified (GM) canola plants (OECD unique identifier: DP-Ø73496-4; hereafter referred to as 73496 canola) containing an insert that expresses the GAT4621 protein conferring tolerance to nonselective herbicidal ingredient glyphosate were evaluated in a subchronic rodent feeding study. Sprague-Dawley rats (12/sex/group) were administered diets containing dehulled, defatted toasted canola meal (DH meal) and refined/bleached/deodorized canola oil (RBD oil) processed from seed of plants that were untreated (73496), sprayed in-field with glyphosate (73496GLY), the non-transgenic near-isogenic (091; control), or one of four commercially available non-GM reference canola varieties (45H72, 45H73, 46A65, 44A89). All diets were formulated as a modification of the standard laboratory chow PMI® Nutrition International, LLC Certified Rodent LabDiet® 5002 (PMI® 5002). DH canola meal and RBD canola oil replaced all commodity soybean fractions typically incorporated in PMI® 5002. No toxicologically significant differences were observed between the test and control groups in this study. The results reported herein support the conclusion that DH meal and RBD oil processed from seed of 73496 canola are as safe and nutritious as DH meal and RBD oil processed from seed of non-GM canola.


Asunto(s)
Ácidos Grasos Monoinsaturados , Herbicidas/farmacología , Animales , Ácidos Grasos Monoinsaturados/química , Femenino , Masculino , Tamaño de los Órganos/efectos de los fármacos , Aceite de Brassica napus , Ratas , Ratas Sprague-Dawley
3.
Food Chem Toxicol ; 53: 417-27, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23261672

RESUMEN

The results from a subchronic feeding study conducted in Sprague­Dawley rats fed with diets containing grain from 4114 (OECD unique identifier: DP-ØØ4114-3) maize that was untreated (4114) or sprayed in field with glufosinate ammonium (4114GLU) in a design similar to previous studies are reported. The test material, 4114 maize, is a hybrid maize produced by transformation with a DNA construct encoding 4 different transgenic proteins for resistance to lepidopteran pests, coleopteran pests, and tolerance to the herbicidal active ingredient glufosinate ammonium. There were a total of 144 rats divided into 12 groups of 12 rats/sex/group. All experimental diets were formulated by Purina Mills, LLC (St. Louis, MO) in accordance with the standards of Purina Mills Labdiet® Certified Rodent LabDiet® 5002. The incorporation rate of maize grain in all diets was 32% (wt/wt). No biologically significant, treatment related differences in body weight, food consumption, clinical pathology parameters (hematology, blood chemistry, urinalysis, or organ weight) were observed in rats consuming the diets containing 4114 maize grain compared with rats fed conventional maize diets. A number of histologic observations were noted in this study but were background lesions and representative of what would be expected for rats of this age and strain. An independent panel of experts determined certain observations to be spontaneous and not related to the test diet. Accordingly, these results support the conclusion that 4114 maize grain is as safe and nutritious as conventional maize grain.


Asunto(s)
Productos Agrícolas/toxicidad , Dieta , Plantas Modificadas Genéticamente/toxicidad , Zea mays/toxicidad , Alimentación Animal , Animales , Peso Corporal , Escarabajos , Productos Agrícolas/genética , Femenino , Herbicidas/farmacología , Lepidópteros , Masculino , Tamaño de los Órganos , Plantas Modificadas Genéticamente/genética , Ratas , Ratas Sprague-Dawley , Urinálisis , Zea mays/genética
4.
Food Chem Toxicol ; 47(9): 2269-80, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19524635

RESUMEN

This 13-week feeding study conducted in Sprague-Dawley rats evaluated the potential health effects from long-term consumption of a rodent diet formulated with grain from genetically modified (GM), herbicide-tolerant maize DP-Ø9814Ø-6 (98140; trade name Optimum GAT (Optimum GAT is a registered trademark of Pioneer Hi-Bred)). Metabolic inactivation of the herbicidal active ingredient glyphosate was conferred by genomic integration and expression of a gene-shuffled acetylase coding sequence, gat4621, from Bacillus licheniformis; tolerance to acetolactate synthase (ALS) inhibiting herbicides was conferred by overexpression of a modified allele (zm-hra) of the endogenous maize ALS enzyme that is resilient to inactivation. Milled maize grain from untreated (98140) and herbicide-treated (98140+Gly/SU) plants, the conventional non-transgenic, near-isogenic control (091), and three commercial non-transgenic reference hybrids (33J56, 33P66, and 33R77) was substituted at concentrations of 35-38% w/w into a common rodent chow formula (PMI) Nutrition International, LLC Certified Rodent LabDiet 5002) and fed to rats (12/sex/group) for at least 91 consecutive days. Compared with rats fed diets containing grain from the conventional near-isogenic control maize, no adverse effects were observed in rats fed diets containing grain from 98140 or 98140+Gly/SU maize with respect to standard nutritional performance metrics and OECD 408-compliant toxicological response variables [OECD, 1998. Section 4 (Part 408), Health Effects: Repeated Dose 90-Day Oral Toxicity Study in Rodents, Guideline for the Testing of Chemicals. Organisation of Economic Co-operation and Development, Paris, France]. These results support the comparative safety and nutritional value of maize grain from genetically modified Optimum GAT and conventional, non-transgenic hybrid field corn.


Asunto(s)
Alimentación Animal/toxicidad , Tolerancia a Medicamentos/genética , Plantas Modificadas Genéticamente/toxicidad , Pruebas de Toxicidad , Zea mays , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Conducta Animal/efectos de los fármacos , Análisis Químico de la Sangre , Peso Corporal/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Ojo/efectos de los fármacos , Femenino , Pruebas Hematológicas , Masculino , Fuerza Muscular/efectos de los fármacos , Sistema Nervioso/efectos de los fármacos , Plantas Modificadas Genéticamente/química , Plantas Modificadas Genéticamente/genética , Ratas , Ratas Sprague-Dawley , Zea mays/genética , Zea mays/metabolismo , Zea mays/toxicidad
5.
Food Chem Toxicol ; 47(7): 1512-20, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19358870

RESUMEN

DAS-Ø15Ø7-1xDAS-59122-7 (1507x59122) is a genetically modified (GM) maize hybrid that was produced by crossing of two GM maize inbreds; DAS-Ø15Ø7-1 and DAS-59122-7. This hybrid cross expresses four transgenic proteins: Cry1F and PAT (from DAS-Ø15Ø7-1) and Cry34Ab1/Cry35Ab1 and PAT (from DAS-59122-7) that confer resistance to lepidopteran and coleopteran pests and tolerance to the herbicidal active ingredient glufosinate-ammonium. The current subchronic feeding study was conducted in Sprague-Dawley rats to evaluate the potential health effects of long-term consumption of a rodent diet containing 1507x59122 maize grain compared with a diet containing maize grain from its near-isogenic control (091). Diets formulated with three unrelated non-GM commercial hybrids (3573, 35P12, 36G12) were also included for within study reference data. All diets contained 34% (w/wt) maize grain and were prepared according to the specifications of PMI((R)) Nutrition International, LLC Certified Rodent LabDiet((R)) 5002 (PMI((R)) 5002). Diets were fed ad libitum to rats for at least 92days. OECD 408 response variables from rats fed the 1507x59122 diet were compared with those from rats fed the 091 control diet. No toxicologically significant differences were observed in nutritional performance variables, clinical and neurobehavioral signs, ophthalmology, clinical pathology (hematology, clinical chemistry, coagulation, and urinalysis), organ weights, and gross and microscopic pathology between rats in the 091 and 1507x59122 treatment groups. The results from this study demonstrate that 1507x59122 maize grain is as safe and nutritious as non-GM maize grain and support the concept that crossing of two safe GM maize events results in production of a safe stacked GM event.


Asunto(s)
Escarabajos , Lepidópteros , Plantas Modificadas Genéticamente/genética , Plantas Modificadas Genéticamente/toxicidad , Zea mays/genética , Zea mays/toxicidad , Animales , Conducta Animal/efectos de los fármacos , Recuento de Células Sanguíneas , Análisis Químico de la Sangre , Coagulación Sanguínea , Peso Corporal , Ingestión de Alimentos , Grano Comestible , Ojo/efectos de los fármacos , Ojo/patología , Femenino , Masculino , Valor Nutritivo , Tamaño de los Órganos , Ratas , Ratas Sprague-Dawley
6.
Crit Rev Toxicol ; 39(1): 76-94, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-18802816

RESUMEN

Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) are environmentally widespread and persistent chemicals with multiple toxicities reported in experimental animals and humans. These compounds can trigger biological activity by activating the alpha isotype of peroxisome proliferator-activated receptors (PPARs), ligand-activated transcription factors that regulate gene expression; however, some biological effects may occur independently of the receptor. Activation of the peroxisome proliferator-activated receptor alpha (PPARalpha) modulates lipid and glucose homeostasis, cell proliferation and differentiation, and inflammation. Reported immunomodulation in experimental animals exposed to PFOA and PFOS has included altered inflammatory responses, production of cytokines and other proteins, reduced lymphoid organ weights, and altered antibody synthesis. Mounting experimental animal evidence suggests PPARalpha independence of some immune effects. This evidence originates primarily from studies with PPARalpha knockout models exposed to PFOA that demonstrate hepatic peroxisome proliferation, reduced lymphoid organ weights, and altered antibody synthesis. As human PPARalpha expression is significantly less than that of rodents, potential PPARalpha independence indicates that future research must explore mechanisms of action of these compounds, including PPARalpha-dependent and -independent pathways. This multiauthored review contains brief descriptions of current and recently published work exploring immunomodulation by PFOA and PFOS, as well as a short overview of other PPARalpha ligands of therapeutic and environmental interest.


Asunto(s)
Ácidos Alcanesulfónicos/inmunología , Ácidos Alcanesulfónicos/toxicidad , Caprilatos/inmunología , Caprilatos/toxicidad , Exposición a Riesgos Ambientales/efectos adversos , Fluorocarburos/inmunología , Fluorocarburos/toxicidad , Factores Inmunológicos/toxicidad , PPAR alfa/metabolismo , Animales , Humanos , Factores Inmunológicos/inmunología , Factores Inmunológicos/metabolismo , PPAR alfa/inmunología , Transactivadores/genética , Transactivadores/metabolismo
7.
Food Chem Toxicol ; 46(12): 3808-17, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18952136

RESUMEN

DP-3Ø5423-1 (305423) is a genetically-modified (GM) soybean that was produced by biolistic insertion of a gm-fad2-1 gene fragment and the gm-hra gene into the germline of soybean seeds. The gm-fad2-1 gene fragment cosuppresses expression of the endogenous FAD2-1 gene encoding the seed-specific omega-6 fatty acid desaturase resulting in higher concentrations of oleic acid (18:1) relative to linoleic acid (18:2). The gm-hra gene encoding a modified acetolactate synthase (ALS) enzyme was used as a selectable marker. In the current study, processed fractions (meal, hulls, and oil) from 305423 soybeans, non-GM soybeans with a similar genetic background (near isoline control) and three commercially-available non-GM varieties were used to formulate diets that were nutritionally comparable to PMI Certified Rodent LabDiet 5002. Diets were fed to young adult Crl:CD(SD) rats (12/sex/group) for approximately 90 days. Compared with rats fed the non-GM control diet, no biologically relevant differences were observed in rats fed the 305423 diet with respect to body weight/gain, food consumption/efficiency, mortality, clinical signs of toxicity, or ophthalmological observations. No test diet-related effects were observed on neurobehavioral assessments, organ weights, or clinical or anatomic pathology. These results demonstrated that 305423 soybeans are as safe and wholesome as non-GM soybeans.


Asunto(s)
Glycine max/química , Glycine max/toxicidad , Ácido Oléico/toxicidad , Animales , Conducta Animal/efectos de los fármacos , Recuento de Células Sanguíneas , Análisis Químico de la Sangre , Coagulación Sanguínea/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Dieta , Ingestión de Alimentos/efectos de los fármacos , Ojo/patología , Femenino , Masculino , Ácido Oléico/análisis , Plantas Modificadas Genéticamente , Ratas , Ratas Sprague-Dawley , Glycine max/genética
8.
Toxicol Sci ; 105(1): 86-96, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18559402

RESUMEN

Repeated high doses of ammonium perfluorooctanoate (APFO) have been reported to affect immune system function in mice. To examine dose-response characteristics in both rats and mice, male CD rats and CD-1 mice were dosed by oral gavage with 0.3-30 mg/kg/day of linear APFO for 29 days. Anti-sheep red blood cell (SRBC) IgM levels, clinical signs, body weights, selected hematology, and lipid parameters, liver weights, spleen, and thymus weights and cell number, selected histopathology, and serum corticosterone concentrations were evaluated. In rats, linear APFO had no effect on production of anti-SRBC antibodies. Ten and 30 mg/kg/day resulted in systemic toxicity as evidenced by decreases in body weight gain to 74 and 37%, and increases in serum corticosterone levels to 135 and 196% of control, respectively. In mice dosed with 10 and 30 mg/kg/day, marked systemic toxicity and stress were observed, as evidenced by a loss in body weight of 3.8 and 6.6 g, respectively (despite a tripling of liver weight), approximately 230% increase in serum corticosterone, and increases in absolute numbers of peripheral blood neutrophils and monocytes with an accompanying decrease in absolute lymphocyte numbers. Immune-related findings at 10 and 30 mg/kg/day that likely represent secondary responses to the systemic toxicity and stress observed at these doses include: decreased IgM antibody production at 10 (20% suppression) and 30 mg/kg/day (28% suppression); decreased spleen and thymus weights and cell numbers; microscopic depletion/atrophy of lymphoid tissue at 10 (thymus) and 30 mg/kg/day (spleen). In summary, no immune-related changes occurred in rats, even at doses causing systemic toxicity. In mice, immune-related changes occurred only at doses causing significant and profound systemic toxicity and stress.


Asunto(s)
Caprilatos/toxicidad , Fluorocarburos/toxicidad , Sistema Inmunológico/efectos de los fármacos , Animales , Recuento de Células Sanguíneas , Peso Corporal/efectos de los fármacos , Corticosterona/sangre , Relación Dosis-Respuesta a Droga , Inmunoglobulina M/biosíntesis , Lípidos/sangre , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Ratones , Ratones Endogámicos ICR , Nivel sin Efectos Adversos Observados , Tamaño de los Órganos/efectos de los fármacos , PPAR alfa/fisiología , Ratas , Ratas Sprague-Dawley , Bazo/efectos de los fármacos , Bazo/patología , Timo/efectos de los fármacos , Timo/patología
9.
Toxicol Sci ; 105(1): 79-85, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18556666

RESUMEN

The mouse local lymph node assay (LLNA) has become the preferred test for evaluating the dermal sensitization potential of chemicals and requirements are now emerging for its use in the evaluation of their formulated products, especially in the European Union. However, despite its widespread use and extensive validation, the use of this assay for directly testing mixtures and formulated products has been questioned, which could lead to repeat testing using multiple animal models. As pesticide formulations are typically a specific complex blend of chemicals for use as aqueous-based dilutions, traditional vehicles prescribed for the LLNA may change the properties of these formulations leading to inaccurate test results and hazard identification. The objective of this study was to evaluate the effectiveness of an aqueous solution of Pluronic L92 block copolymer surfactant (L92) as a vehicle in the mouse LLNA across five laboratories. Three chemicals with known sensitization potential and four pesticide formulations for which the sensitization potential in guinea pigs and/or humans had previously been assessed were used. Identical LLNA protocols and test materials were used in the evaluation. Assessment of the positive control chemicals, hexylcinnamaldehyde, formaldehyde, and potassium dichromate revealed positive results when using 1% aqueous L92 as the vehicle. Furthermore, results for these chemicals were reproducible among the five laboratories and demonstrated consistent relative potency determinations. The four pesticide formulations diluted in 1% aqueous L92 also demonstrated reproducible results in the LLNA among the five laboratories. Results for these test materials were also consistent with those generated previously using guinea pigs or from human experience. These data support testing aqueous compatible chemicals or pesticide formulations using the mouse LLNA, and provide additional support for the use of 1% aqueous L92 as a suitable, aqueous-based vehicle.


Asunto(s)
Ensayo del Nódulo Linfático Local , Plaguicidas/química , Plaguicidas/toxicidad , Poloxámero/química , Tensoactivos/química , Acroleína/análogos & derivados , Acroleína/toxicidad , Animales , Química Farmacéutica , Femenino , Formaldehído/toxicidad , Guías como Asunto , Humanos , Laboratorios , Ratones , Ratones Endogámicos CBA , Vehículos Farmacéuticos , Plantas/efectos de los fármacos , Dicromato de Potasio/toxicidad
10.
Food Chem Toxicol ; 46(6): 2201-13, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18403083

RESUMEN

Optimum GAT1 soybean is a genetically modified (GM) soybean containing event DP-356Ø43-5 (356043) that was produced by integration of the coding sequences of the GAT4601 and GM-HRA proteins. In planta expression of these proteins confers tolerance to glyphosate and sulfonylurea/imidazolinone herbicides, respectively. This paper reports the results from a subchronic rat feeding study conducted with 356043 soybeans. Dehulled/defatted toasted meal and toasted ground hulls were prepared from soybeans from untreated plants (356043), herbicide-treated plants (356043+Gly/SU), non-transgenic isoline control (091), and three commercial non-transgenic reference varieties (93B86, 93B15, and 93M40). Individual diets conforming to standard certified rodent chow formulation (Purina Rodent LabDiet) 5002) were prepared with 20% meal (w/w) and 1.5% hulls (w/w). Diets were fed to young adult Sprague-Dawley rats (12/sex/group) for at least 93 days. Compared with rats fed the isoline control or conventional reference diets, no biologically-relevant, adverse effects were observed in rats fed diets containing 356043 or 356043+Gly/SU soybean with respect to body weight/gain, food consumption/efficiency, clinical signs, mortality, ophthalmology, neurobehavioral assessments (sensory response, grip strength, motor activity), clinical pathology (hematology, coagulation, serum chemistry, urinalysis), organ weights, and gross and microscopic pathology. The results from this study indicate that 356043 soybeans are as safe and nutritious as conventional non-GM soybeans.


Asunto(s)
Glycine max/genética , Glycine max/toxicidad , Herbicidas/toxicidad , Plantas Modificadas Genéticamente/genética , Plantas Modificadas Genéticamente/toxicidad , Animales , Conducta Animal/efectos de los fármacos , Recuento de Células Sanguíneas , Análisis Químico de la Sangre , Coagulación Sanguínea/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Dieta , Ingestión de Alimentos/efectos de los fármacos , Oftalmopatías/inducido químicamente , Oftalmopatías/patología , Femenino , Masculino , Actividad Motora/efectos de los fármacos , Tamaño de los Órganos/efectos de los fármacos , Desempeño Psicomotor/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Urinálisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...